LMAN2 anticorps (C-Term)
Aperçu rapide pour LMAN2 anticorps (C-Term) (ABIN2302417)
Antigène
Voir toutes LMAN2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 284-314, C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- LMAN2, CT (LMAN2, C5orf8, Vesicular integral-membrane protein VIP36, Glycoprotein GP36b, Lectin mannose-binding 2, Vesicular integral-membrane protein 36)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- LMAN2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 284-314 amino acids from the C-terminal region of human LMAN2.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- LMAN2 (Lectin, Mannose-Binding 2 (LMAN2))
-
Autre désignation
- LMAN2
-
NCBI Accession
- NP_006807
-
UniProt
- Q12907
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-